118 related articles for article (PubMed ID: 8970640)
1. Mizoribine as an alternative to azathioprine in pediatric renal transplantation.
Faraj G; Cochat P; Serre-Beauvais F; Vialtel P; Chevallier C; Cuzin B; Bouvier R; Lachaux A
Transplantation; 1996 Dec; 62(11):1701-2. PubMed ID: 8970640
[No Abstract] [Full Text] [Related]
2. Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.
Mita K; Akiyama N; Nagao T; Sugimoto H; Inoue S; Osakabe T; Nakayama Y; Yokota K; Sato K; Uchida H
Transplant Proc; 1990 Aug; 22(4):1679-81. PubMed ID: 2202125
[No Abstract] [Full Text] [Related]
3. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
[No Abstract] [Full Text] [Related]
4. Mizoribine as an alternative to azathioprine in triple-therapy immunosuppressant regimens in cadaveric renal transplantation.
Lee HA; Slapak M; Venkatraman G; Mason J; Digard N; Wise M
Transplant Proc; 1993 Aug; 25(4):2699-700. PubMed ID: 8356720
[No Abstract] [Full Text] [Related]
5. Mizoribine as an alternative to azathioprine in triple therapy immunosuppressant regimens in cadaveric renal transplantation: two successive studies.
Lee HA; Slapak M; Raman GV; Mason JC; Digard N; Wise M
Transplant Proc; 1995 Feb; 27(1):1050-1. PubMed ID: 7878799
[No Abstract] [Full Text] [Related]
6. Role of mizoribine in renal transplantation.
Tsuzuki K
Pediatr Int; 2002 Apr; 44(2):224-31. PubMed ID: 11896891
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation.
Okamoto M; Yoshimura N; Nakai I; Nakajima H; Ushigome H; Sakaguchi K; Ohmori Y; Yoshimura R; Sugioka N; Oka T
Transplant Proc; 2000 Nov; 32(7):1716-7. PubMed ID: 11119905
[No Abstract] [Full Text] [Related]
8. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
Nomura Y; Tomikawa S; Beck Y; Nishimura Y; Meigata K; Ando Y; Kikuchi K
Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
[No Abstract] [Full Text] [Related]
9. The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial).
Cho DK; Kim JH; Park SH; Kim JC; Kim CD; Baek MY; Kim SJ; Kim SH; Kwon TH; Kim YL; Kim YW; Chang SK
Transplant Proc; 2001; 33(7-8):3256-8. PubMed ID: 11750394
[No Abstract] [Full Text] [Related]
10. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
[No Abstract] [Full Text] [Related]
11. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan.
Akiyama T; Okazaki H; Takahashi K; Hasegawa A; Tanabe K; Uchida K; Takahara S; Toma H
Transplant Proc; 2005 Mar; 37(2):843-5. PubMed ID: 15848551
[No Abstract] [Full Text] [Related]
12. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation.
Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520
[No Abstract] [Full Text] [Related]
13. The argument for the use of mizoribine in renal transplantation: a meta-analysis and systemic review.
Zhang X; Fu S; Han S; Zheng X; Wang L
Transpl Immunol; 2013 Mar; 28(2-3):106-11. PubMed ID: 23313278
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results of short-term combination immunosuppressions of mizoribine, azathioprine, and prednisolone with pretreatment to canine kidney transplantation.
Minami T; Watanabe T; Muto M; Wakao Y; Suzuki T; Takahashi M
J Vet Med Sci; 1993 Jun; 55(3):409-14. PubMed ID: 8357913
[TBL] [Abstract][Full Text] [Related]
15. The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantation.
Anguita A; Repetto HA; Rodriguez-Rilo L; Vazquez LA; Iturzaeta A; Morrone G; Deheza R; Maldonado L; Goldberg JL
Transplant Proc; 1999 Sep; 31(6):2279. PubMed ID: 10500576
[No Abstract] [Full Text] [Related]
16. Plasma endothelin level following kidney transplantation.
Kumano K; Masui N; Soh S; Mashimo S; Endo T
Transplant Proc; 1994 Aug; 26(4):2114-6. PubMed ID: 8066688
[No Abstract] [Full Text] [Related]
17. Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
Tojimbara T; Kimikawa M; Nakajima I; Sato S; Nakamura M; Ishida H; Tanabe K; Koyama I; Utsumi K; Sannomiya A; Tsuji K; Fuchinoue S; Agishi T
Transplant Proc; 1999 Nov; 31(7):2763-4. PubMed ID: 10578282
[No Abstract] [Full Text] [Related]
18. Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
Kyo M; Ichikawa Y; Hanafusa T; Fukunishi T; Nagano S; Takahara S; Kokado Y; Okuyama A; Ihara H; Ito K; Sagawa S; Sonoda T; Akiyama T; Kurita T; Suzuki S; Amemiya H
Transplant Proc; 1996 Apr; 28(2):910-1. PubMed ID: 8623457
[No Abstract] [Full Text] [Related]
19. Experience with the use of mizoribine in human renal transplantation.
Dohi K; Yahata H; Fukuda Y; Takenaka M; Tabe Y; Ono E; Fukuda M; Omotehara T; Eto T; Ezaki H
Hiroshima J Med Sci; 1984 Dec; 33(4):809-12. PubMed ID: 6398817
[No Abstract] [Full Text] [Related]
20. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
